Ping An Healthcare and Technology Company (1833) H2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2024 earnings summary
10 Jun, 2025Executive summary
Achieved first full-year profitability in 2024, with net profit of RMB88.3 million, marking a historic milestone.
Total revenue grew 2.9% year-on-year to RMB4.81 billion, driven by strong B-end (corporate) and F-end (integrated finance/individual) business growth.
Senior care services revenue surged 413.5% year-over-year, unlocking new business potential.
Deepened collaboration and formal consolidation with Ping An Group, driving synergies in insurance, health, and senior care services.
Leveraged AI and digital transformation to enhance service quality, efficiency, and reduce expense ratios.
Financial highlights
Revenue reached RMB4.81 billion, up 2.9% year-over-year; gross profit RMB1,523.4 million, up 1.0%.
Senior care revenue hit RMB282.8 million, up 413.5% year-over-year.
Net profit: RMB88.3 million (2023: loss of RMB334.9 million); adjusted net profit: RMB158.5 million.
Gross margin: 31.7%; expense ratios declined by 14.4 percentage points year-over-year.
Operating cash flows turned positive at RMB99 million; cash and equivalents at year-end: RMB2,044.7 million.
Outlook and guidance
Plans to continue investing in AI, with RMB35 million allocated for 2025.
Focus on expanding core business, especially in senior care and corporate health checkups, targeting high-margin segments.
Ongoing expansion of F-end and B-end business scenarios, leveraging digital health technologies.
Enhanced synergies with Ping An Group to support customer acquisition and retention.
Expects sustained high growth in senior care and corporate health management, leveraging demographic trends.
Latest events from Ping An Healthcare and Technology Company
- Revenue up 13.7% and adjusted net profit up 161.3% year-on-year, led by corporate health management.1833
H2 202524 Mar 2026 - Net profit surged 136.8% on 19.5% revenue growth, driven by AI, margin gains, and a special dividend.1833
H1 20256 Jan 2026 - Returned to profit in H1 2024, driven by cost control and rapid growth in strategic segments.1833
Q2 20242 Dec 2025 - Revenue and profit surged, driven by corporate health and AI-enabled service expansion.1833
Q3 202523 Oct 2025 - Q1 2025 saw robust revenue and profit growth, fueled by healthcare-insurance synergy and AI innovation.1833
Q1 20256 Jun 2025